Clinical trials
Phase 1 Dementia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Allyx Therapeutics | 1 |
| GAAD Medical Research Institute Inc. | 1 |
| Hearthstone Alzheimer Care | 1 |
| Kukjeon Pharmaceutical Co.,Ltd. | 1 |
| Libella Gene Therapeutics | 1 |
| Mount Sinai Hospital, Canada | 1 |
| Neurological Associates of West Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 7 |
| Alzheimer Disease | 2 |
| Cognition Disorders | 1 |
| Cognitive Dysfunction | 1 |
| Frontotemporal Dementia | 1 |
| Major Depressive Disorder | 1 |
| Psychomotor Agitation | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.